United Kingdom (UK) Antiparasitic Market (2025-2031) | Outlook, Forecast, Industry, Companies, Value, Trends, Analysis, Competitive Landscape, Growth, Segmentation, Size & Revenue, Share

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3.1 United Kingdom (UK) Country Macro Economic Indicators

3.2 United Kingdom (UK) Antiparasitic Market Revenues & Volume, 2021 & 2031F

3.3 United Kingdom (UK) Antiparasitic Market - Industry Life Cycle

3.4 United Kingdom (UK) Antiparasitic Market - Porter's Five Forces

3.5 United Kingdom (UK) Antiparasitic Market Revenues & Volume Share, By Drug Class, 2021 & 2031F

3.6 United Kingdom (UK) Antiparasitic Market Revenues & Volume Share, By Disease Indication, 2021 & 2031F

3.7 United Kingdom (UK) Antiparasitic Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing prevalence of parasitic infections in animals in the UK

4.2.2 Growing awareness among pet owners about the importance of parasite prevention

4.2.3 Rise in pet ownership and spending on pet healthcare in the UK

4.3 Market Restraints

4.3.1 Stringent regulations governing the use of antiparasitic products in animals

4.3.2 Emerging resistance to existing antiparasitic drugs

4.3.3 Economic instability impacting disposable income for pet healthcare expenses

6.1 United Kingdom (UK) Antiparasitic Market, By Drug Class

6.1.1 Overview and Analysis

6.1.2 United Kingdom (UK) Antiparasitic Market Revenues & Volume, By Drug Class, 2021- 2031F

6.1.3 United Kingdom (UK) Antiparasitic Market Revenues & Volume, By Anthelmintics, 2021- 2031F

6.1.4 United Kingdom (UK) Antiparasitic Market Revenues & Volume, By Antiprotozoals, 2021- 2031F

6.1.5 United Kingdom (UK) Antiparasitic Market Revenues & Volume, By Others, 2021- 2031F

6.2 United Kingdom (UK) Antiparasitic Market, By Disease Indication

6.2.1 Overview and Analysis

6.2.2 United Kingdom (UK) Antiparasitic Market Revenues & Volume, By Giardiasis, 2021- 2031F

6.2.3 United Kingdom (UK) Antiparasitic Market Revenues & Volume, By Trichuriasis, 2021- 2031F

6.2.4 United Kingdom (UK) Antiparasitic Market Revenues & Volume, By Filariasis, 2021- 2031F

6.2.5 United Kingdom (UK) Antiparasitic Market Revenues & Volume, By Neurocysticercosis, 2021- 2031F

6.2.6 United Kingdom (UK) Antiparasitic Market Revenues & Volume, By Hydatid disease, 2021- 2031F

6.2.7 United Kingdom (UK) Antiparasitic Market Revenues & Volume, By Others, 2021- 2031F

6.3 United Kingdom (UK) Antiparasitic Market, By Distribution Channel

6.3.1 Overview and Analysis

6.3.2 United Kingdom (UK) Antiparasitic Market Revenues & Volume, By Hospital pharmacies, 2021- 2031F

6.3.3 United Kingdom (UK) Antiparasitic Market Revenues & Volume, By Retail pharmacies, 2021- 2031F

6.3.4 United Kingdom (UK) Antiparasitic Market Revenues & Volume, By Online pharmacies, 2021- 2031F

6.3.5 United Kingdom (UK) Antiparasitic Market Revenues & Volume, By Others, 2021- 2031F

7.1 United Kingdom (UK) Antiparasitic Market Export to Major Countries

7.2 United Kingdom (UK) Antiparasitic Market Imports from Major Countries

8.1 Number of veterinary prescriptions for antiparasitic products

8.2 Adoption rate of newer, more effective antiparasitic treatments

8.3 Frequency of veterinary visits for parasite prevention consultations

9.1 United Kingdom (UK) Antiparasitic Market Opportunity Assessment, By Drug Class, 2021 & 2031F

9.2 United Kingdom (UK) Antiparasitic Market Opportunity Assessment, By Disease Indication, 2021 & 2031F

9.3 United Kingdom (UK) Antiparasitic Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F

10.1 United Kingdom (UK) Antiparasitic Market Revenue Share, By Companies, 2024

10.2 United Kingdom (UK) Antiparasitic Market Competitive Benchmarking, By Operating and Technical Parameters